Lloyd T Lam

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 8

Top Topics

Acute Myeloid Leukemia

Brain Metastases

Dna Damage Response

Top Venues

Molecular cancer research : MCR

Molecular cancer therapeutics

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Joshua P Plotnik, Zheng Zha, Weiguo Feng, Irene I Lee, Jacob Riehm, Ryan A McClure, Stephanie Sandoval, Tamar Uziel, Erin Murphy, Xin Lu, Lloyd T Lam
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular cancer research : MCR 22 (8) (2024)
Joshua P Plotnik, Zheng Zha, Weiguo Feng, Irene I Lee, Jacob Riehm, Ryan A McClure, Stephanie Sandoval, Tamar Uziel, Erin Murphy, Xin Lu, Lloyd T Lam
MYC family amplification dictates sensitivity to BET bromodomain protein inhibitor Mivebresib (ABBV-075) in small-cell lung cancer. Molecular cancer research : MCR (2024)
Joshua P Plotnik, Zheng Zha, Weiguo Feng, Irene I Lee, Jacob Riehm, Ryan A McClure, Stephanie Sandoval, Tamar Uziel, Erin Murphy, Xin Lu, Lloyd T Lam
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular cancer research : MCR 22 (8) (2024)
Joshua P Plotnik, Zheng Zha, Weiguo Feng, Irene I Lee, Jacob Riehm, Ryan A McClure, Stephanie Sandoval, Tamar Uziel, Erin Murphy, Xin Lu, Lloyd T Lam
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular cancer research : MCR 22 (8) (2024)
Joshua P Plotnik, Zheng Zha, Weiguo Feng, Irene I Lee, Jacob Riehm, Ryan A McClure, Stephanie Sandoval, Tamar Uziel, Erin Murphy, Xin Lu, Lloyd T Lam
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung Cancer. Molecular cancer research : MCR 22 (8) (2024)
Lu Zhang, Tianyu Cai, Xiaoyu Lin, Xiaoli Huang, Mai H Bui, Joshua P Plotnik, Richard J Bellin, Emily J Faivre, Vinitha M Kuruvilla, Lloyd T Lam, Xin Lu, Zheng Zha, Weiguo Feng, Paul Hessler, Tamar Uziel, Qi Zhang, Antonio Cavazos, Lina Han, Debra C Ferguson, Gaurav Mehta, Sriram S Shanmugavelandy, Terrance J Magoc, Jenny Rowe, Neal C Goodwin, Kathleen A Dorritie, Michael Boyiadzis, Daniel H Albert, Keith F McDaniel, Warren M Kati, Marina Konopleva, Yu Shen
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia. Molecular cancer therapeutics 20 (10) (2021)
J Scott Lee, Andrew W Roberts, Dennis Juarez, Thanh-Trang T Vo, Shruti Bhatt, Lee-Or Herzog, Sharmila Mallya, Richard J Bellin, Suresh K Agarwal, Ahmed Hamed Salem, Tu Xu, Jia Jia, Lingxiao Li, John R Hanna, Matthew S Davids, Angela G Fleischman, Susan O'Brien, Lloyd T Lam, Joel D Leverson, Anthony Letai, Jonathan H Schatz, David A Fruman
Statins enhance efficacy of venetoclax in blood cancers. Science translational medicine 10 (445) (2019)
Rui Wang, Yupeng He, Valerie Robinson, Ziping Yang, Paul Hessler, Loren M Lasko, Xin Lu, Anahita Bhathena, Albert Lai, Tamar Uziel, Lloyd T Lam
Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP. Molecular cancer therapeutics 17 (12) (2018)